{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T18:02:44Z","timestamp":1723140164741},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T00:00:00Z","timestamp":1236902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1000305","type":"journal-article","created":{"date-parts":[[2009,3,12]],"date-time":"2009-03-12T21:30:08Z","timestamp":1236893408000},"page":"e1000305","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Timing the Emergence of Resistance to Anti-HIV Drugs with Large Genetic Barriers"],"prefix":"10.1371","volume":"5","author":[{"given":"Pankhuri","family":"Arora","sequence":"first","affiliation":[]},{"given":"Narendra M.","family":"Dixit","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2009,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV drug resistance.","volume":"350","author":"F Clavel","year":"2004","journal-title":"N Engl J Med"},{"key":"ref2","first-page":"62","article-title":"Update of the drug resistance mutations in HIV-1: Spring 2008.","volume":"16","author":"VA Johnson","year":"2008","journal-title":"Top HIV Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.","volume":"271","author":"AS Perelson","year":"1996","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JVI.69.8.5087-5094.1995","article-title":"Lower in-vivo mutation-rate of human-immunodeficiency-virus type-1 than that predicted from the fidelity of purified reverse-transcriptase.","volume":"69","author":"LM Mansky","year":"1995","journal-title":"J Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/JVI.74.3.1234-1240.2000","article-title":"High rate of recombination throughout the human immunodeficiency virus type 1 genome.","volume":"74","author":"AE Jetzt","year":"2000","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1128\/JVI.77.20.11193-11200.2003","article-title":"High rates of human immunodeficiency virus type 1 recombination: Near-random segregation of markers one kilobase apart in one round of viral replication.","volume":"77","author":"T Rhodes","year":"2003","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1073\/pnas.0306764101","article-title":"Dynamics of HIV-1 recombination in its natural target cells.","volume":"101","author":"DN Levy","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","first-page":"31","article-title":"Advances in antiretroviral therapy.","volume":"16","author":"TJ Wilkin","year":"2008","journal-title":"Top HIV Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jama.300.5.555","article-title":"Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society\u2014USA panel.","volume":"300","author":"SM Hammer","year":"2008","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2005.07.003","article-title":"Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir.","volume":"68","author":"L Doyon","year":"2005","journal-title":"Antiviral Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/aid.2007.0173","article-title":"Resistance profile of darunavir: Combined 24-week results from the POWER trials.","volume":"24","author":"S de Meyer","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/jac\/dki127","article-title":"Drug resistance and antiretroviral drug development.","volume":"55","author":"RW Shafer","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jmv.21139","article-title":"Updated prevalence of genotypic resistance among HIV-1 positive patients naive to antiretroviral therapy: a single center analysis.","volume":"80","author":"G Lapadula","year":"2008","journal-title":"J Med Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002030-199805000-00006","article-title":"The frequency of resistant mutant virus before antiviral therapy.","volume":"12","author":"RM Ribeiro","year":"1998","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QAD.0b013e3282f3f16d","article-title":"Lopinavir\/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.","volume":"22","author":"JFO Delfraissy","year":"2008","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1056\/NEJMoa074609","article-title":"Class-sparing regimens for initial treatment of HIV-1 infection.","volume":"358","author":"SA Riddler","year":"2008","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350601100106","article-title":"An open-label, randomized comparative pilot study of a single-class quadruple therapy regimen versus a 2-class triple therapy regimen for individuals initiating antiretroviral therapy.","volume":"11","author":"G Moyle","year":"2006","journal-title":"Antivir Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/108729104323076007","article-title":"Preventing and managing antiretroviral drug resistance.","volume":"18","author":"DR Kuritzkes","year":"2004","journal-title":"AIDS Patient Care STDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/QAI.0b013e318050d8c2","article-title":"HIV-infected patients receiving lopinavir\/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%.","volume":"45","author":"J Shuter","year":"2007","journal-title":"J Acquir Immun Defic Syndr"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jmv.21034","article-title":"Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugs.","volume":"80","author":"CF Perno","year":"2008","journal-title":"J Med Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/00002030-200009080-00009","article-title":"Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples.","volume":"14","author":"BA Larder","year":"2000","journal-title":"AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00003495-200868010-00004","article-title":"Antiretroviral therapy: optimal sequencing of therapy to avoid resistance.","volume":"68","author":"JL Martinez-Cajas","year":"2008","journal-title":"Drugs"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1128\/JVI.00712-06","article-title":"Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.","volume":"80","author":"JD Baxter","year":"2006","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.tim.2006.10.001","article-title":"Stochastic or deterministic: what is the effective population size of HIV-1?","volume":"14","author":"RD Kouyos","year":"2006","journal-title":"Trends Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1073\/pnas.93.12.6106","article-title":"Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure.","volume":"93","author":"L Moutouh","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1128\/JVI.00083-07","article-title":"Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment.","volume":"81","author":"T Nora","year":"2007","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/bies.10386","article-title":"Recombination in HIV and the evolution of drug resistance: for better or for worse?","volume":"26","author":"MT Bretscher","year":"2004","journal-title":"Bioessays"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1128\/JVI.79.21.13572-13578.2005","article-title":"Stochastic interplay between mutation and recombination during the acquisition of drug resistance mutations in human immunodeficiency virus type 1.","volume":"79","author":"CL Althaus","year":"2005","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1099\/vir.0.81138-0","article-title":"A genetic-algorithm approach to simulating human immunodeficiency virus evolution reveals the strong impact of multiply infected cells and recombination.","volume":"86","author":"G Bocharov","year":"2005","journal-title":"J Gen Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1098\/rsif.2005.0064","article-title":"HIV recombination: what is the impact on antiretroviral therapy?","volume":"2","author":"C Fraser","year":"2005","journal-title":"J R Soc Interface"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/molbev\/msl189","article-title":"Increasing sequence correlation limits the efficiency of recombination in a multisite evolution model.","volume":"24","author":"S Gheorghiu-Svirschevski","year":"2007","journal-title":"Mol Biol Evol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1099\/vir.0.83668-0","article-title":"Recombination increases HIV fitness but not necessarily diversity.","volume":"89","author":"NNV Vijay","year":"2008","journal-title":"J Gen Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/17469600.2.4.375","article-title":"Modelling HIV infection dynamics: The role of recombination in the development of drug resistance.","volume":"2","author":"NM Dixit","year":"2008","journal-title":"Future HIV Ther"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198504184.001.0001","article-title":"Virus Dynamics: Mathematical Principles of Immunology and Virology","author":"MA Nowak","year":"2000"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri700","article-title":"Modelling viral and immune system dynamics.","volume":"2","author":"AS Perelson","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1568005033481042","article-title":"Mathematical approaches in the study of viral kinetics and drug resistance in HIV-1 infection.","volume":"3","author":"V Muller","year":"2003","journal-title":"Curr Drug Targets Infect Disord"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1371\/journal.pcbi.0030205","article-title":"Emergence of recombinant forms of HIV: dynamics and scaling.","volume":"3","author":"GW Suryavanshi","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.antiviral.2007.06.010","article-title":"Protease inhibitor resistance in HIV-infected patients: molecular and clinical perspectives.","volume":"76","author":"JL Martinez-Cajas","year":"2007","journal-title":"Antiviral Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1073\/pnas.0407498102","article-title":"HIV dynamics with multiple infections of target cells.","volume":"102","author":"NM Dixit","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/JVI.79.3.1666-1677.2005","article-title":"Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events.","volume":"79","author":"TD Rhodes","year":"2005","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/tpbi.1997.1358","article-title":"Waiting with and without recombination: the time to production of a double mutant.","volume":"53","author":"FB Christiansen","year":"1998","journal-title":"Theor Popul Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.1073\/pnas.97.14.7681","article-title":"Production of resistant HIV mutants during antiretroviral therapy.","volume":"97","author":"RM Ribeiro","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/s00018-006-6009-7","article-title":"Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance.","volume":"63","author":"P Yin","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/418144a","article-title":"Multiply infected spleen cells in HIV patients.","volume":"418","author":"A Jung","year":"2002","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/0042-6822(92)90038-Q","article-title":"Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus-particles.","volume":"186","author":"H Sato","year":"1992","journal-title":"Virology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1128\/JVI.78.16.8942-8945.2004","article-title":"Multiplicity of human immunodeficiency virus infections in lymphoid tissue.","volume":"78","author":"NM Dixit","year":"2004","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1128\/JVI.70.9.6044-6053.1996","article-title":"CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef.","volume":"70","author":"BK Chen","year":"1996","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0092-8674(00)80715-1","article-title":"Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of \u03b2-COP in endosomes.","volume":"97","author":"V Piguet","year":"1999","journal-title":"Cell"},{"key":"ref49","article-title":"Introduction to Probability Models","author":"SM Ross","year":"2007"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1098\/rspb.1996.0231","article-title":"Viral quasi-species and recombination.","volume":"263","author":"MC Boerlijst","year":"1996","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"ref51","article-title":"Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications","author":"J Gabrielson","year":"2000"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1128\/JVI.79.7.4025-4032.2005","article-title":"Analysis of human immunodeficiency virus cytopathicity by using a new method for quantitating viral dynamics in cell culture.","volume":"79","author":"C Speirs","year":"2005","journal-title":"J Virol"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T16:02:57Z","timestamp":1710172977000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1000305"}},"subtitle":[],"editor":[{"given":"Christophe","family":"Fraser","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2009,3,13]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1000305","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,13]]}}}